CTRI/2024/10/075501尚未招募3 期
Comparison of efficacy and tolerability of levetiracetam and valproate for newly diagnosed generalised and unclassifiable epilepsy in adolescent girls aged 10-18 years: a randomized controlled trial
Dr Suthiraj S1 个研究点 分布在 1 个国家目标入组 302 人开始时间: 2024年10月31日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 302
- 试验地点
- 1
- 主要终点
- Number of participants with seizure freedom
研究概览
简要总结
In this RCT we want to compare the efficacy and tolerability of two commonly used anti-seizure medications; valproate and levetiracetam in adolecsent girls with generalized and unclassifiable epilepsy aged 10-18 years. Both drugs will be administered to participants for 24 weeks and we will compare the number of patienst with seizure freedom and adverse effects in both groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 10.00 Year(s) 至 18.00 Year(s)(—)
- 性别
- Female
入选标准
- •1.Newly diagnosed case of generalized or unclassifiable epilepsy 2.History of at least one convulsive seizure within previous one month.
排除标准
- •Parents not providing informed consent
- •Adolescent suffering fromc hronic hepatic or renal disease
- •Only acute symptomatic seizures.
结局指标
主要结局
Number of participants with seizure freedom
时间窗: At 24 weeks
次要结局
- Number of participants with any adverse effect due to study medication(24 weeks)
研究者
Dr Suthiraj S
AIIMS, Rishikesh
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older AdultsEpilepsyNCT07422233Nasim Tabrizi137
尚未招募
4 期
Treatment of Seizures in Neonate With HIENCT07284498Mansoura University66
尚未招募
2 期
Efficacy of Probenecid on Cluster Seizures During Anti Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG MonitoringNCT07318870Fondation Ophtalmologique Adolphe de Rothschild600
已完成
不适用
Levetiracetam Versus Phenobarbitone for the Treatment of Neonatal Seizures in a Tertiary Care Hospital.NCT07401433Hayat Abad Medical Complex, Peshawar260
招募中
3 期
KISS Evaluation of early administration of Levetiracetam in the prevention and treatment of delirium during septic shock: a randomized, double-blind, placebo-controlled trial.2023-510449-51-00Assistance Publique Hopitaux De Paris280
